SEC Form 4 · accession 0001567619-19-005272
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Lane
Officer — Corporate Vice President
Period of report
Feb 20, 2019
Accepted (ET)
Feb 22, 2019 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2019 | M | 3,322 | $4,584.00 | A | 6,468 | D | |
| Common StockF1 | Feb 20, 2019 | S | 736 | $211.5801 | D | 5,732 | D | |
| Common StockF2 | holding | — | — | — | 592 | I | by spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right-to-buy)F4,F3 | $45.84 | Feb 20, 2019 | M | 3,322 | D | — | Feb 13, 2023 | Common Stock | 3,322 | 0 | D |
Explanation of responses
- F1Represents the weighted average sales price of the shares sold ranging from a low of $211.5801 to a high of $211.5810 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F2Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
- F3Grant of option to buy 1,661 shares of IDEXX Laboratories, Inc. common stock that became exercisable on the fifth anniversary of the date of grant without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- F4Not applicable.